ATE282954T1 - Methode zur konservierung von leukozyten mittels cla - Google Patents

Methode zur konservierung von leukozyten mittels cla

Info

Publication number
ATE282954T1
ATE282954T1 AT01112782T AT01112782T ATE282954T1 AT E282954 T1 ATE282954 T1 AT E282954T1 AT 01112782 T AT01112782 T AT 01112782T AT 01112782 T AT01112782 T AT 01112782T AT E282954 T1 ATE282954 T1 AT E282954T1
Authority
AT
Austria
Prior art keywords
cla
leukocytes
preserving
preserving leukocytes
image
Prior art date
Application number
AT01112782T
Other languages
English (en)
Inventor
Mark E Cook
Michael W Pariza
Ellen B Cook
James L Stahl
Frank M Graziano
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE282954T1 publication Critical patent/ATE282954T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01112782T 1996-02-27 1996-08-27 Methode zur konservierung von leukozyten mittels cla ATE282954T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/607,498 US5585400A (en) 1996-02-27 1996-02-27 Methods of attenuating the allergic response in animals

Publications (1)

Publication Number Publication Date
ATE282954T1 true ATE282954T1 (de) 2004-12-15

Family

ID=24432537

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96930612T ATE226434T1 (de) 1996-02-27 1996-08-27 Konjugierte linolsäuren zur abschwächung allergischer reaktionen
AT01112782T ATE282954T1 (de) 1996-02-27 1996-08-27 Methode zur konservierung von leukozyten mittels cla

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT96930612T ATE226434T1 (de) 1996-02-27 1996-08-27 Konjugierte linolsäuren zur abschwächung allergischer reaktionen

Country Status (9)

Country Link
US (1) US5585400A (de)
EP (2) EP1126022B1 (de)
JP (1) JP2000506840A (de)
AT (2) ATE226434T1 (de)
AU (1) AU6959396A (de)
DE (2) DE69633949D1 (de)
DK (1) DK0883681T3 (de)
ES (1) ES2180792T3 (de)
WO (1) WO1997032008A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262119B1 (en) 1996-04-12 2001-07-17 Peptide Technology Limited Methods of treating immunopathologies using polyunsaturated fatty acids
JP3051375B2 (ja) 1997-11-13 2000-06-12 リノール油脂株式会社 共役リノール酸を有効成分とする抗アレルギー剤
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
ATE310511T1 (de) * 1997-12-12 2005-12-15 Purdue Research Foundation Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
JPH11209279A (ja) * 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
US6042869A (en) 1998-02-20 2000-03-28 Natural Nutrition Ltd. Bulk animal feeds containing conjugated linoleic acid
JP2000516480A (ja) * 1998-03-17 2000-12-12 コンリンコ，インコーポレイテッド 共役リノール酸組成物
US6015833A (en) 1998-03-17 2000-01-18 Conlinco., Inc. Conjugated linoleic acid compositions
US7776353B1 (en) 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
US7078051B1 (en) 1998-08-11 2006-07-18 Natural Asa Conjugated linoleic acid alkyl esters in feedstuffs and food
US6077525A (en) * 1998-04-10 2000-06-20 The George Washington University Use of conjugated linoleic acids
US6214372B1 (en) 1998-05-04 2001-04-10 Con Lin Co., Inc. Method of using isomer enriched conjugated linoleic acid compositions
US6696584B2 (en) 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6060514A (en) 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
US7101914B2 (en) * 1998-05-04 2006-09-05 Natural Asa Isomer enriched conjugated linoleic acid compositions
KR100655838B1 (ko) * 1998-05-04 2006-12-12 콘린코 인크. 이성질체가 강화된 공액 리놀레산 조성물
US6413545B1 (en) 1998-09-01 2002-07-02 Access Business Group International Llc Diet composition and method of weight management
GB9828380D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
US6440931B1 (en) 1999-02-23 2002-08-27 Natural Corporation Conjugated linoleic acid in treatment and prophylaxis of diabetes
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
US7947737B1 (en) 1999-09-30 2011-05-24 Aker Biomarine Asa Method of treating hypertension and reducing serum lipase activity
US6420577B1 (en) 1999-12-01 2002-07-16 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Method for commercial preparation of conjugated linoleic acid
US6432469B1 (en) 2000-02-17 2002-08-13 Natural Corporation Bulk animal feeds containing conjugated linoleic acid
US6482434B1 (en) 2000-04-04 2002-11-19 Wisconsin Alumni Research Foundation Method for reducing adverse effects of a weight loss regimen
JP2004506746A (ja) * 2000-04-06 2004-03-04 コンリンコ，　インコーポレイテッド 共役リノール酸組成物
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
CA2405819C (en) 2000-04-18 2010-02-09 Duane Fimreite Conjugated linoleic acid powder
US6380409B1 (en) * 2000-04-24 2002-04-30 Conlin Co., Inc. Methods for preparing CLA isomers
DE10102050A1 (de) 2001-01-17 2002-07-18 Basf Ag Zubereitung zur Verbesserung der Nahrungsverwertung
US6395782B1 (en) 2001-03-02 2002-05-28 Wisconsin Alumni Research Foundation Method of increasing longevity and preventing body weight wasting in autoimmune disease by using conjugated linoleic acid
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
AU2002257714B2 (en) 2001-03-29 2007-06-28 Basf Aktiengesellschaft Conjugated unsaturated glyceride mixtures and a method for producing the same
EP1264893A1 (de) 2001-06-08 2002-12-11 Teagasc Dairy Products Research Centre Biosynthese von CLA durch Bifidobakterien
US6677470B2 (en) 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
US6414171B1 (en) 2001-11-27 2002-07-02 Her Majesty In Right Of Canada, As Represented By The Minister Of Agriculture & Agri-Food Canada Method for commercial preparation of conjugated linoleic acid from by-products of vegetable oil refining
US6409649B1 (en) 2001-11-27 2002-06-25 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture & Agri-Food Canada Method for commercial preparation of conjugated linoleic acid using recycled alkali transesterification catalyst
US7700833B2 (en) 2002-03-01 2010-04-20 Cornell University Process for the production of unsaturated fatty acids
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
US6743931B2 (en) 2002-09-24 2004-06-01 Natural Asa Conjugated linoleic acid compositions
US20050014832A1 (en) * 2003-07-16 2005-01-20 Lc Usa Llc Treatment
DE10332712A1 (de) * 2003-07-18 2005-02-10 Cognis Deutschland Gmbh & Co. Kg Verwendung von c9,t11-Isomeren der konjugierten Linolsäure
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
US20080193550A1 (en) * 2004-05-11 2008-08-14 Fonterra Corporate Research And Development Limited Cla-Enriched Milkfat and Uses Thereof
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
EP1963517A1 (de) 2005-12-24 2008-09-03 Teagasc Dairy Products Research Centre Verfahren zur herstellung von trans-10-cis-12-octadecadiensäure
EP1923066A1 (de) * 2006-11-08 2008-05-21 Cognis IP Management GmbH Eine Zusammensetzung enthaltend Rotbuschtee und konjugierte Linolsäure
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
TW201300121A (zh) * 2011-06-30 2013-01-01 Univ Nat Taiwan 山苦瓜組成物在製備改善過敏性氣喘藥物之用途
EP3474839B1 (de) 2016-06-23 2024-07-31 Stepan Specialty Products, LLC Zusammensetzungen enthaltend rumensäure-reiche konjugierte linolsäure für gehirngesundheit
WO2018009334A1 (en) 2016-07-08 2018-01-11 Stepan Specialty Products, Llc Compositions comprising rumenic acid-rich conjugated linoleic acid for joint health

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110559C2 (de) * 1981-03-18 1985-05-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Vollsynthetisches Zellkulturmedium
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS62209023A (ja) * 1986-03-10 1987-09-14 Sunstar Inc 抗アレルギ−剤
JPS6398355A (ja) * 1986-10-16 1988-04-28 Kazumitsu Maruta 動物用飼料
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations

Also Published As

Publication number Publication date
DE69624508T2 (de) 2003-06-18
DK0883681T3 (da) 2002-12-30
AU6959396A (en) 1997-09-16
EP1126022A3 (de) 2002-04-03
ES2180792T3 (es) 2003-02-16
DE69633949D1 (de) 2004-12-30
EP1126022A2 (de) 2001-08-22
EP0883681A1 (de) 1998-12-16
US5585400A (en) 1996-12-17
WO1997032008A1 (en) 1997-09-04
EP1126022B1 (de) 2004-11-24
ATE226434T1 (de) 2002-11-15
DE69624508D1 (de) 2002-11-28
EP0883681B1 (de) 2002-10-23
JP2000506840A (ja) 2000-06-06

Similar Documents

Publication Publication Date Title
DE69633949D1 (de) Methode zur Konservierung von Leukozyten mittels CLA
DE69007855D1 (de) Pumpe zur biomedizinischen Verwendung.
DE3772121D1 (de) Abtastendoskop zur chirurgischen verwendung.
DE3878685D1 (de) Implantat zur fixierung von wirbeln.
DE69424522D1 (de) Methode zur resuspendierung von zellreichen konzentraten
DE3875714D1 (de) Vorrichtung zur beleuchtung von dokumenten.
DE3786641D1 (de) Einheit zur aufnahme von blutbestandteilen.
DE69323983D1 (de) Methode zur Modifizierung des Fettdruckes von Buchstaben
DE68914460D1 (de) Polymer-zusammensetzung zur sauerstoff-entfernung.
DE3577650D1 (de) Vorrichtung zur dehnung von koerpergewebe.
DE3887794D1 (de) System zur Gerätkompatibilitätssicherung.
ATE106221T1 (de) Zahnimplantat zur befestigung von zahnersatz- suprakonstruktionen.
DE69306071D1 (de) Endoskopische Vorrichtung zur Herstellung von Knoten
DE3782592D1 (de) Methode zum erzielen von optischer modulation.
DE68916653D1 (de) Methode zur herstellung von lichtwellenleiterreihen.
DE3876453D1 (de) Methode zur kontrolle von staubbildung.
DE3884173D1 (de) Chirurgische Klemme.
DE58907242D1 (de) Vorrichtung zur Lichtversorgung von Endoskopen.
DE68905117D1 (de) Verfahren zur stabilisierung von blutgewinnungsfaktoren.
ATE317127T1 (de) Methode zur stabilisierung von plättchen
DE3778301D1 (de) Facettenlinsen-einheit zur beleuchtung.
DE3889524D1 (de) Methode zur Stabilisierung von eingesättigten Organosilicium-Zusammensetzungen.
DE68922665D1 (de) Methode zur optischen Kopplung.
DE69022707D1 (de) Methode zur Fluordecarboxylierung.
ATE239038T1 (de) Methode zur reinigung von keratinocyten- wachstumsfaktoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties